RECURSION PHARMACEUTICALS, INC. - RXRX
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 07, 2026 | SCHEDULE 13G | STATE STREET CORPORATION | 6.6% | 34,706,130 | View |
| Jul 31, 2026 | SCHEDULE 13G | Vanguard Portfolio Management | 5.97% | 31,369,274 | View |
| Jul 31, 2026 | SCHEDULE 13G | Vanguard Capital Management | 5.09% | 26,744,129 | View |
| Jul 29, 2026 | SCHEDULE 13G/A | BlackRock, Inc. | 8.5% | 44,541,605 | View |
| May 12, 2026 | SCHEDULE 13G | STATE STREET CORPORATION | 5.5% | 28,490,638 | View |
| Apr 24, 2026 | SCHEDULE 13G/A | BlackRock, Inc. | 7.2% | 37,821,797 | View |
| Mar 27, 2026 | SCHEDULE 13G/A | The Vanguard Group | 0.0% | 0 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.